An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Clinical trial NCT01260480 · UNKNOWN

Trial details

NCT number: NCT01260480
Sponsor: Aposense Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms

Start date: 2010-12-01
Primary completion: 2012-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.